Home / Intelligence / White Papers / Tethering to Reality: Integrating HCP-level Real-World Data into Brand Share Estimation
Share estimates from demand studies in primary market research (PMR) are a critical input for any forecast—their accuracy is paramount for successful brand planning.
Successful prediction is often elusive—from 2020 through 2022, only one in ten products had actual performance that aligned with forecasted expectations.*
Recognizing this challenge, Trinity experts developed a method that significantly improves prediction of future prescribing behavior in demand studies.
The Challenge
It is often difficult for Healthcare Professionals (HCPs) to offer precise share estimates when responding to surveys in PMR. HCPs typically do not think about their prescribing behavior holistically in their daily practice—they may have recall bias, recency bias towards newer brands, or some combination of factors. Some of these estimation errors may be overcome by using real or simulated patient chart-based methods (e.g., patient simulation, chart abstraction) that capture clinical decision-making rather than methods based on an aggregate recall of their prescribing behavior (i.e., percentage-based share estimates from a share allocation exercise). Still, there are several factors that physicians may not be able to appropriately consider when thinking about a future market being evaluated in the study, such as patients actually filling or refilling the script, insurance coverage, formulary restrictions, sales and marketing efforts by the manufacturer, etc.
Complete the form below to access the full white paper
We would contact you in accordance with our Privacy Policy, which we invite you to visit for details about our data privacy practices, including, where appropriate, how you may access and correct the personal data we store or withdraw consent to the collection, use or disclosure of such information. We will not share your email address or personal information. If you would like to opt out in the future, please email _compliance@trinitylifesciences.com.
Related Intelligence
Webinars
Navigating the Early Asset Evaluation Journey with Confidence
February 25, 2025 | 1:00 – 1:45 PM ET
There is no room for missteps along the journey to evaluate the viability of assets in early stages of development. When making go/no go decisions, many critical questions must be answered across the early asset lifecycle. Join a team of cross-functional experts for a lively panel discussion on how to approach early commercial assessment with insight from various perspectives.
Sign Up Now
Webinars
Behavioral Science & Concept Testing Research: Getting Deeper Responses than “I Hate the Color Blue”
Available On Demand
High-impact, optimized marketing communication materials are vital, no matter where a brand is in the product lifecycle. Taking tactical research in general—and concept or message testing in particular—to the next level becomes a key focus. Join Lisa Bailey, a Managing Director in Trinity Life Sciences’ Insights Practice, as she hosts a wide-ranging discussion on tips […]
Watch Now
Blog
RWD + PMR = Tethering Demand Forecasts to Reality
Reliable forecast models are a cornerstone of any successful commercialization plan. The inputs that drive those forecast models are critical. From 2020 through 2022: Only 1 in 10 products had performance aligned with forecasted expectations* Nearly 60% underperformed their forecast expectations More than 30% overperformed Forecast models often rely on healthcare professional (HCP)-reported behavioral data. […]
Read More